Prostate Cancer & BPHArchives
Suicide risk in prostate cancer patients: epidemiological trends and a predictive modeling
Prostate Cancer & BPH 5 min.
Prostate cancer is the second most prevalent malignancy globally and the fifth leading cause of cancer-related mortality in males [1].Researchers have extensively investigated factors influencing cancer mortality to develop more effective intervention strategies. A substantial proportion of PCa patients...
Green tea catechins and prostate cancer: mechanisms, clinical evidence, and safety: a narrative review
Prostate Cancer & BPH 8 min.
The International Agency for Research on Cancer (IARC) estimated that approximately 20 million new cancer cases and 9.7 million cancer-related deaths occurred worldwide in 2022, with one in six of all deaths being due to cancer [1]. Prostate cancer (PCa) is the second most common cancer among men worldwide...
Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis
Prostate Cancer & BPH 5 min.
In Japan, prostate cancer (PC) incidence and mortality rates are increasing [1, 2–3]. In 2022, there were an estimated 96,400 new cases of PC in Japan, and approximately 13,300 deaths were attributable to the disease [2]. The rise in PC cases in Japan is due in part to Japan’s aging population...
Transperineal cognitive fusion MRI-targeted biopsy shows higher detection rates than systematic biopsy in prostate cancer: a prospective cohort study
Prostate Cancer & BPH 5 min.
Systematic biopsy (SBx) has traditionally been the gold standard for diagnosing prostate cancer, but its clinical application has significant limitations [1, 2]. Although 12-core systematic biopsy has largely replaced the traditional sextant biopsy, its random sampling strategy still cannot overcome...
